Clinical trial
The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting
NCT07253727 is registered in ClinicalTrials.gov with Olympus Europe SE & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting
- Lead sponsor
- Olympus Europe SE & Co. KG
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2025
- Completion date
- August 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bronchoscopy